BrightSpring Health Services (BTSG) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
10 Apr, 2026Executive summary
Annual Meeting scheduled for May 21, 2026, to be held virtually, with voting on three key proposals: election of Class II directors, ratification of KPMG LLP as auditor, and advisory approval of executive compensation.
Shareholders of record as of March 30, 2026, are eligible to vote; 193,167,731 shares outstanding.
Forward-looking statements caution that actual results may differ due to various risks and uncertainties.
Voting matters and shareholder proposals
Proposal 1: Elect three Class II directors (Olivia Kirtley, Max Lin, Steve Miller) to serve until 2029.
Proposal 2: Ratify KPMG LLP as independent registered public accounting firm for 2026.
Proposal 3: Advisory, non-binding vote on compensation of named executive officers.
Board recommends voting FOR all proposals.
Shareholders may submit proposals for the 2027 Annual Meeting by December 21, 2026.
Board of directors and corporate governance
Board divided into three classes with staggered terms; current nominees have extensive healthcare, financial, and governance experience.
Board operates through Audit, Compensation, Nominating and Corporate Governance, and Quality and Compliance Committees.
As of June 2025, no longer a “controlled company” under Nasdaq rules, but transition exemptions apply until June 2026.
Majority of directors are independent; independence reviewed annually.
Board leadership combines CEO and Chairman roles; no Lead Director currently elected.
Latest events from BrightSpring Health Services
- Virtual annual meeting to vote on directors, auditor ratification, and executive pay.BTSG
Proxy filing10 Apr 2026 - Strong 2025 growth and double-digit 2026 outlook fueled by acquisitions and efficiency.BTSG
Q4 20257 Apr 2026 - Double-digit growth and strong financial outlook driven by integration, scale, and M&A.BTSG
Investor Day 202618 Mar 2026 - AI-driven efficiency, specialty growth, and strong provider performance fuel expansion and flexibility.BTSG
Leerink Global Healthcare Conference 202610 Mar 2026 - Strong growth, margin expansion, and strategic M&A drive positive outlook despite IRA headwinds.BTSG
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - Q2 revenue up 26% to $2.73B, Adjusted EBITDA $139.1M, and guidance raised for 2024.BTSG
Q2 20242 Feb 2026 - Integrated care, operational excellence, and targeted M&A drive sustained above-market growth.BTSG
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Double-digit growth, strong Q1, and rapid M&A integration drive market leadership.BTSG
Jefferies Global Healthcare Conference1 Feb 2026 - Disciplined M&A and integrated care fuel robust, double-digit EBITDA growth and market expansion.BTSG
Morgan Stanley 22nd Annual Global Healthcare Conference21 Jan 2026